Anglia Ruskin Clinical Trials Unit (ARCTU) is a research partnership between Anglia Ruskin Universities' Postgraduate Medical Institute, NHS Trusts from Cambridgeshire, Essex and Hertfordshire, and industry partners. Together, our NHS Trusts cover a local patient population of over 3 million. In addition, our two tertiary centres; The Essex Cardiothoracic Centre and St Andrews Centre for Plastic Surgery and Burns, takes this population to over 10 million.
Our aim is to work with hospital trusts, healthcare providers, commissioners and commercial companies to increase opportunities for patients to take part in both investigator led and commercial trials.
For our investigator led trials we aim to support investigators through each step of the clinical trial lifecycle. We offer investigators the support to take their study from a basic idea and develop it into a well-designed study. An investigator can be anyone working in a clinical environment (e.g. doctors, nurses and allied health professionals).
We also work with SMEs (small to medium-sized enterprises) and larger commercial companies who are looking to test their products in a clinical environment. The support we offer ranges from providing advice on the regulatory environment in the UK, to helping to plan and run large scale studies.
Alongside the investigator initiated work, we also have a partnership with Quintiles, the world's largest Contract Research Organisation. This work supports the delivery of studies from the Quintiles pipeline at our local partner trusts.
For more information on our current studies, please click here.
|Title||Automated Quantification of Stroke Damage on Brain Computer Tomography Scans: e-ASPECTS|
|Authors||James Hampton-Till, Michael Harrison, Anna Luisa Kühn, Oliver Anderson, Devesh Sinha, Sharon Tysoe, Eric Greveson, Michalis Papadakis, Iris Q. Grunwald|
||European Medical Journal (EMJ) – Neurology
|Title||Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial|
|Authors||Sreekanth Palvai, Michael Harrison, Sharon Shibu Thomas, Karen Hayden, James Green, Oliver Anderson, Lavinia Romero, Richard Lodge, Patricia Burns, Imtiaz Ahmed|
|Journal||JMIR Research Protocols|
Michael Harrison, CTU Director
Karen Hayden, Trials Data Manager
Trisha Parker, Clinical Trials Coordinator
Laura Giles, Clinical Trials Unit Administrator
Tomer Regev, Project Manager
Jufen Zhang, Trials Statistician
For trials related enquiries please contact Trisha Parker (Clinical Trials Coordinator)
0845 196 4938
Anglia Ruskin Clinical Trials Unit
Post Graduate Medical Institute
Anglia Ruskin University
Bishops Hall Lane
Chelmsford, CM1 1SQ
Fax: 01245 68 4437
For all other enquiries please email: email@example.com